Navigation Links
Moffitt Cancer Center researchers validate molecular signature to predict radiation therapy benefit
Date:8/15/2012

Researchers at Moffitt Cancer Center, working with colleagues in Sweden, the Netherlands and Puerto Rico, have validated a radiosensitivity molecular signature that can lead to better radiation therapy decisions for treating patients with breast cancer.

The results appeared in a recent issue of Clinical Cancer Research, a publication of the American Association for Cancer Research.

The study examined patients with breast cancer who had been treated with radiation therapy and demonstrated that a radiosensitivity molecular signature (RSI) could predict clinical outcomes exclusively in patients treated with radiation therapy. The radiosensitivity molecular signature (RSI) used by the research team had previously been tested and validated for rectal, esophageal, and head and neck cancers. The technology, which identifies radiosensitivity and radioresistance, opens the door to biologically guided radiation therapy and offers the potential for better outcomes.

"Developing a radiosensitivity predictive assay has been a goal of radiation biology for decades," said Javier F. Torres-Roca, M.D., member of the Experimental Therapeutics program at Moffitt. "This effort supports the emphasis on personalized medicine, where the goal is to use molecular signatures to guide therapeutic decisions."

According to Torres-Roca, approximately 60 percent of all cancer patients receive radiation therapy during their treatment. Yet until now, no molecular diagnostic or biomarker of radiosensitivity had been developed to predict its benefit.

The radiosensitivity molecular signature was developed based on gene expression for 10 specific genes and a linear regression algorithm. RSI was developed in 48 cancer cell lines using a systems-biology strategy focused on identifying biomarkers for cellular radiosensitivity.

This study validated RSI's benefit when researchers found that radiosensitive breast cancer patients had an improv
'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Moffitt Cancer Center researchers discover how cancer cells hijack a mechanism to grow
2. Attitudes toward outdoor smoking ban at moffitt Cancer Center evaluated
3. Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
4. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
5. Moffitt Cancer Center study validates activity of rare genetic variant in glioma
6. Moffitt researchers find cutaneous human papillomavirus infection a risk factor for skin cancer
7. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
8. Sun exposure and cutaneous HPV infection found synergistic in skin cancers, Moffitt says
9. Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says
10. Moffitt researchers: Darwins principles say cancer will always evolve to resist treatment
11. Moffitt researcher, colleagues find success with new immune approach to fighting some cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... August 21, 2014 While golfing in ... it hard to stay focused on his game due ... The constant whine, slapping and continual need to spray ... methods to stay protected from insects while golfing. He ... in the Financial Services/Investment Banking Industry, decided to change ...
(Date:8/21/2014)... Atlantic Information Services, Inc. (AIS) — industry-leading ... The AIS Report on Blue Cross & Blue Shield ... Association or its member companies) — is pleased to ... Management Insight Series. Bundled Payment Models: Bottom-Line Strategies ... — Horizon Healthcare Services, Inc. and Arkansas Blue Cross ...
(Date:8/21/2014)... San Diego, CA (PRWEB) August 21, 2014 ... website daily regarding all the latest information from the ... Solution . , The US FDA announced on August ... Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II), ... to the presence of particulate matter. , The ...
(Date:8/21/2014)... Sometimes you have to lose the life of your dreams ... to a Hundred: Finding My Purpose through My Pain,” Jason Roy, ... broken family, a childhood of gang violence and two life-altering car ... to be,” Roy said. “I didn’t give up on God when ... today of helping others overcome their trials.” , He said his ...
(Date:8/21/2014)... August 21, 2014 OpsAssure, the ... start-ups selected to participate in the Harbor Accelerator's ... mentorship, curriculum sessions and valuable resources.he Harbor’s goal ... the region. Each start-up selected for the program ... order to help businesses grow quickly, test markets ...
Breaking Medicine News(10 mins):Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2
... , , OAKLAND, Calif. , Jan. 13 ... have responded in less than one day to the call by ... assistance to residents of earthquake devastated Haiti —leading the ... support these efforts with donations of funds to support travel costs ...
... ... ... 2010 -- Connextions Inc. today announced the appointment of Kenneth A. Burdick ... with an outstanding record of management and fiscal performance with the nation’s most respected ...
... , KIRKLAND, Wash. , Jan. 13 Long term ... Lifetime Television,s Balancing Act show. Denise Gott , the featured expert, ... term care for our loved ones. "Three in four will eventually need ... (LTCFP), one of America,s most experienced long term care insurance ...
... , ... the trusted leader in acne treatment for 15 years, today ... revolutionized the treatment of acne now enhanced with exclusive micro-crystal ... to penetrate even clogged pores quickly is the first change ...
... surgeons say , WEDNESDAY, Jan. 13 (HealthDay News) -- ... coaxed a donor trachea to grow its own network ... for months in the recipient,s arm. , The innovative ... trachea (windpipe), but it did so without the need ...
... treatment, researcher says, , WEDNESDAY, Jan. 13 (HealthDay News) -- ... turn cancerous. , At issue is how mutations occur in ... Jan. 13 in Nature , researchers report that cancer-causing ... , "The bad news is that it is much easier ...
Cached Medicine News:Health News:National Conference Call Thursday for 1,500 RN Volunteers for Haiti Relief Effort 2Health News:Veteran Health Insurance Senior Executive Joins Connextions Inc. Board of Directors 2Health News:Veteran Health Insurance Senior Executive Joins Connextions Inc. Board of Directors 3Health News:Long Term Care Insurance Expert Featured on Lifetime Television's Balancing Act Show 2Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 2Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 3Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 4Health News:Proactiv(R) Introduces New Micro-Crystal Technology and Unprecedented Customer Access to Expert Acne Treatment Advice 5Health News:Transplanted Trachea Grows Own Blood Supply in Patient's Arm 2Health News:Transplanted Trachea Grows Own Blood Supply in Patient's Arm 3
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
(Date:8/20/2014)... 20, 2014   Easy Breathe , the fastest growing online ... Easy Blog " - has received more than 4.5 million unique ... "We are thrilled that so many people are finding our blog ... Easy Breathe. "We,re committed to making sleep apnea more widely known ... informed about sleep apnea news , troubleshooting advice , ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4
... U.S. Food and Drug Administration recently approved the NovoTTF-100A ... multiforme (GBM) that recurs or progresses after receiving chemotherapy ... Brain tumors are the growth of ... National Cancer Institute, each year about 19,000 people in ...
... announced that the U.S. Food and Drug Administration ... treatment of adult patients with glioblastoma multiforme (GBM) ...  The portable, wearable device delivers an anti-mitotic, anti-cancer ... The NovoTTF is a novel, first-in-class treatment option ...
Cached Medicine Technology:FDA Approves New Medical Device for Form of Brain Cancer 2FDA Approves New Medical Device for Form of Brain Cancer 3FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 2FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 3FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors 4
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: